☰ Menu
× Close

VT – Vyripharm Technologies

Leading The Way

Big Data and IoT Platform

Biotechnology Informatics Infrastructure

Vyripharm Technologies (VT) is building the data collection, repository and analytics infrastructure called Biopharmaceutical Informatics Infrastructure.

API and Cloud-based Biomedical Informatics Infrastructure based on Block-Chain Architecture

Vyripharm Technologies, the Company’s IT/Big Data and IoT Platform has patent pending a blockchain architecture called the Biotechnology Informatics Infrastructure (“BI²™”), to compliment the testing platform which will be developed as an integrated medicinal supply chain technological tracking system/verification including forward/backward product traceability, chain of custody and patient tracking of outcomes. Vyripharm Technologies (VT) is building the data collection, repository and analytics infrastructure called Biopharmaceutical Informatics Infrastructure (BI²™).

 

 

Bridging the Big Data/IOT Gap with BI²™

BI²™ bridges the gap between cultivators, processors, R&D, Big Pharma biotechnology, and the medical community. This blockchain data repository contains an immutable ledger whereby each stakeholder at each step in the supply chain provides data that is collected, measured, tested, certified, verified, traced and tracked.  BI²™ allows optimal data collection and mining to perform true evidence-based omics data to clinical trials data, enabling evidence-based medicine to be applied to the integration of the health care industry. VT will generate revenue from BI²™ from fees collected from stakeholders at all points in the value chain as well as data mining interests such as product developers and research institutions and government agencies.

Read More

 

Connect With Us

Contact Us